← Back to patent-cliff list

CAS 330786-24-8

3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Codes: IBRT-005, (III)461018-2-a, (IX)461018-4-a, (VIII)461018-6-a, (VI)461018-7-a, (VI)461018-9-a, (VII)461018-10-a, (VI)461018-12-a, (III)461018-14-a, (VIIa)461018-15-a, (III)461018-17-a, (VI)461018-20-a +5 more

Application context (from source-drug indications)

Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibAcute myeloid leukaemiaHYML-122

Source drugs (routes using this intermediate)

DrugTierExpiry
IbrutinibTier A — Act now2027
HYML-122Tier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.